Simvastatin inhibits IFN-γ-induced CD40 gene expression by suppressing STAT-1α
Open Access
- 16 May 2007
- journal article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 82 (2) , 436-447
Abstract
CD40, a member of the TNF receptor superfamily, is critical for productive immune responses. Macrophages constitutively express CD40 at low levels, which are enhanced by IFN-γ. IFN-γ-induced CD40 expression involves activation of STAT-1α as well as NF-κB activation through an autocrine response to IFN-γ-induced TNF-α production. Statins are 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors, which exert anti-inflammatory effects independent of their cholesterol-lowering actions. Herein, we describe that simvastatin (SS) inhibits IFN-γ-induced CD40 expression via the suppression of STAT-1α expression. This results in diminished STAT-1α recruitment to the CD40 promoter upon IFN-γ treatment, in addition to reduced RNA Polymerase II recruitment and diminished levels of H3 and H4 histone acetylation. SS-mediated inhibition of STAT-1α occurs through suppression of constitutive STAT-1α mRNA and protein expression. The inhibitory effect of SS on CD40 and STAT-1α is dependent on HMG-CoA reductase activity, as the addition of mevalonate reverses the inhibitory effect. In addition, CD40 and/or STAT-1α expression is inhibited by GGTI-298 or Clostridium difficile Toxin A, a specific inhibitor of Rho family protein prenylation, indicating the involvement of small GTP-binding proteins in this process. Collectively, these data indicate that SS inhibits IFN-γ-induced CD40 expression by suppression of STAT-1α, and altering transcriptional events at the CD40 promoter.Keywords
Funding Information
- National Institutes of Health (NS45290, NS36765)
- National Multiple Sclerosis Society (PP1129)
This publication has 64 references indexed in Scilit:
- Molecular regulation of CD40 gene expression in macrophages and microgliaBrain, Behavior, and Immunity, 2004
- Regulation of JAK–STAT signalling in the immune systemNature Reviews Immunology, 2003
- Role of CD40 ligand in amyloidosis in transgenic Alzheimer's miceNature Neuroscience, 2002
- CD40 signaling and Alzheimer's disease pathogenesisNeurochemistry International, 2001
- The CD40/CD154 receptor/ligand dyadRID="†"ID="†" ReviewCellular and Molecular Life Sciences, 2001
- Serine phosphorylation of STATsOncogene, 2000
- Reduction of atherosclerosis in mice by inhibition of CD40 signallingNature, 1998
- CD40L blockade prevents autoimmune encephalomyelitis and hampers TH1 but not TH2 pathway of T cell differentiationJournal of Molecular Medicine, 1997
- CELLULAR RESPONSES TO INTERFERON-γAnnual Review of Immunology, 1997
- CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis.Proceedings of the National Academy of Sciences, 1996